Charline Ogier
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Behavioral Neuroscience top 10%
- Stress Responses and Cortisol
Papers in
- Oncology 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Epigenetics and DNA Methylation 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Anthony Brureau (1 shared paper)Tangui Maurice (1 shared paper)G. Ixart (1 shared paper)Charleine Zussy (1 shared paper)Laurent Givalois (1 shared paper)Thierry Chardès (3 shared papers)Véronique Garambois (3 shared papers)André Pèlegrin (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Cancer Letters (1 paper)International Journal of Cancer (1 paper)Neurobiology of Aging (1 paper)PubMed (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Charline Ogier
7 papers receiving 217 citations
Peers
Comparison fields: 5 of 49
- Biological Psychiatry 29
- Behavioral Neuroscience 32
- Oncology 79
- Cancer Research 26
- Physiology 41
Countries citing papers authored by Charline Ogier
This map shows the geographic impact of Charline Ogier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charline Ogier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charline Ogier more than expected).
Fields of papers citing papers by Charline Ogier
This network shows the impact of papers produced by Charline Ogier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charline Ogier. The network helps show where Charline Ogier may publish in the future.
Co-authors
The 25 scholars most cited alongside Charline Ogier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 88 | |
| 2 | 2018 | 45 | |
| 3 | 2019 | 44 | |
| 4 | 2022 | 29 | |
| 5 | 2017 | 13 | |
| 6 | 2023 | 2 | |
| 7 | [Decreased percentage of circulating T-lymphocytes in patients with thalassemic trait]. | 1984 | 1 |
About Charline Ogier
Charline Ogier is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Social Psychology, having authored 7 papers that have together received 222 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers), Epigenetics and DNA Methylation (1 paper), Ferroptosis and cancer prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Biological Psychiatry (29 citations), Behavioral Neuroscience (32 citations), Oncology (79 citations), Cancer Research (26 citations) and Physiology (41 citations). Charline Ogier has collaborated with scholars based in France and United States. Frequent co-authors include Anthony Brureau, Tangui Maurice, G. Ixart, Charleine Zussy, Laurent Givalois, Thierry Chardès, Véronique Garambois, André Pèlegrin, Christel Larbouret and Marta Jarlier. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Letters, International Journal of Cancer, Neurobiology of Aging and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.